Outsourcing

CDMO Landscape Changes

The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.

RNA’s Expanding Horizons

Contract manufacturing services for GMP-grade RNA are in demand.

Packaging Biologic Drugs for Clinical Trials

Biologic drugs used in clinical trials need technologies to meet the unique requirements of each study.

VIVEbiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapies

June 08, 2021

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

AGC Biologics to Supply More Plasmid DNA for Pfizer-BioNTech COVID-19 Vaccine

June 08, 2021

AGC Biologics has partnered with BioNTech to further supply plasmid DNA starting material from its Heidelberg, Germany, facility for the Pfizer-BioNTech COVID-19 vaccine.

Development Strategies for Cell and Gene Therapy Methods

June 01, 2021

The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.

Developing a Method for Success through Partnerships

June 01, 2021

Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.

CDMO Landscape Seeing Changes as Consolidation Continues

May 16, 2021

The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.

RNA’s Expanding Horizons

May 16, 2021

As the RNA therapeutic market grows, contract manufacturing services for GMP-grade RNA are in demand and expected to continue on an upward trajectory.

Challenges When Outsourcing Viral Safety Services

May 16, 2021

Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.

Ensuring Contract Manufacturing Facilities Are Up to Speed

May 16, 2021

The COVID-19 pandemic has triggered additional considerations to supplier oversight of contract manufacturing facilities.

Demystifying Complex Clinical Trial Kit Prep

May 15, 2021

Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.

Evolving Analytical Technology Unravels Protein Characteristics

May 02, 2021

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.